Why it matters
The pharmaceuticals context.
Post-pandemic supply-chain pressure and bipartisan concern about US reliance on overseas active-pharmaceutical-ingredient (API) production drove an unprecedented wave of domestic pharmaceutical capacity announcements beginning in 2023. Eli Lilly, Novo Nordisk, and Johnson & Johnson lead capacity commitments that exceed any peer's investment in the prior two decades, much of it tied to GLP-1, oncology, and biologics demand.
Project record
At a glance
- Company
- Merck
- Industry
- Pharmaceuticals
- Location
- Wilmington, Delaware
- Investment
- $1.00B
- Expected jobs
- 500
- Status
- Under Construction
- Announced
- Apr 9, 2024
- Expected opening
- Dec 1, 2025
- Added to tracker
- Apr 15, 2025
Sources
Official references
- Primary source https://www.merck.com/stories/
Related
Other projects to know
Back to the tracker/projects/merck-wilmington